Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety, Patient Safety in Surgery

Por um escritor misterioso
Last updated 31 janeiro 2025
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Incremental doses of intravenous labetalol are safe and effective and, at times, such therapy may need to be augmented by a continuous infusion of labetalol to control severe hypertension. Continuous infusions of labetalol may exceed the recommended maximum daily dose of 300 mg on occasion. We report a case in which hypertension occurring after an abdominal aortic aneurysm repair, initially responsive to intermittent intravenous beta-blockade, became resistant to this therapy leading to the choice of an intravenous labetalol infusion as the therapeutic option. The labetalol infusion resulted in a profound cardiovascular compromise in this postoperative critically ill patient. While infusions of labetalol have successfully been used, prolonged administration in the intensive care unit requires vigilance and the establishment of a therapeutic rationale/policy for interventions, such as the ready availability of glucagon, β-agonists, phosphodiesterase inhibitors, insulin, and vasopressin when severe cardiovascular depression occurs.
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Frontiers Management of Blood Pressure During and After Recanalization Therapy for Acute Ischemic Stroke
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Pharmacology Basicmedical Key
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Part 12: Cardiac Arrest in Special Situations
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
PDF) Safety and efficacy of continuous intravenous labetalol for blood pressure control in neurosurgical patients
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Labetalol Tablets: Package Insert
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
LABETALOL HYDROCHLORIDE INJECTION USP
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
PDF) Hypotensive effect of labetalol and dexmedetomidine blood loss and surgical conditions in functional endoscopic sinus surgery: A double‑blind randomized clinical trial
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Labetalol: Package Insert
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
IM 3 Flashcards
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Labetalol Hydrochloride
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Hemodynamic Safety of Continuous Infusion Labetalol Versus Esmolol Combination Therapies for Type B Aortic Dissections
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Effects of nitroglycerin versus labetalol on peripheral perfusion during deliberate hypotension for sinus endoscopic surgery: a randomized, controlled, double-blinded trial, BMC Anesthesiology
Labetalol infusion for refractory hypertension causing severe hypotension  and bradycardia: an issue of patient safety, Patient Safety in Surgery
Hypertensive emergency - EMCrit Project

© 2014-2025 likytut.eu. All rights reserved.